Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oncophage in Recurrent Soft Tissue Sarcoma
NCT00005628Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 1999
- Primary completion
- Aug 2001
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of vitespen in soft tissue sarcoma (STS), sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 1999; status: completed.
02
Drugs
vitespen
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00005628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005628.